Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
In this video series, Dr. Paul Romesser discusses recent advances in HPV related cancers, including treatment options, vaccination recommendations and patient perspectives.
To watch the full playlist click here.
In this latest update to the Lung Cancer Video Library, Oncologists discuss a variety of topics in lung cancer including biomarker testing, immunotherapy, KRAS+, emerging therapies, the changes that have occurred in treating NSCLC in the past few decades, Lung Cancer risk factors, and treatment options.
To watch the full playlist click here.
This program aims to give those diagnosed with cancer a voice to share their experiences participating in clinical trials and help others understand the importance of participating in clinical trials.
Dr. Sridevi Rajeeve gives an overview of Amyloidosis types, signs, and symptoms, including AL Amyloidosis and treatment options.
To watch the full playlist click here.
Drs. Matthew Kurian, Karan Jatwani, and Karine Tawagi discuss risk factors for developing prostate cancer, PSA test in prostate cancer screening, biopsies in prostate cancer, among other relevant information about prostate cancer.
To watch the full playlist click here.
Dr. Gladys Rodriguez and Hannah Manella, RD, discuss addressing nutritional concerns of patients who are undergoing cancer care.
Drs. Shetal Patel, Siddharth Sheth, and Jared Weiss discuss the most recent advances in head and neck cancer treatment, including curable and incurable head and neck cancers, thyroid cancers, and HPV positive and negative cancers.
At our live event, Lung Cancer OncTalk 2023, Dr. Puneeth Iyengar discusses using radiation therapy in metastatic lung cancer, advances in Oligometastatic disease, (SBRT) for Oligoprogressive, The NRG-LU Trial, and future goals of metastatic NSCLC Treatment.
To watch the complete playlist click here.
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock